Dr. Nadezhda Gonzalez, MD

NPI: 1568874667
Total Payments
$139.56
2022 Payments
$18.36
Companies
6
Transactions
9
Medicare Patients
517
Medicare Billing
$70,651

Payment Breakdown by Category

Food & Beverage$139.56 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $139.56 9 100.0%

Top Paying Companies

Company Total Records Latest Year
KCI USA, Inc. $37.24 2 $0 (2020)
PFIZER INC. $33.39 3 $0 (2019)
Janssen Pharmaceuticals, Inc $19.56 1 $0 (2020)
ABBVIE INC. $18.36 1 $0 (2022)
Merck Sharp & Dohme Corporation $15.96 1 $0 (2018)
Allergan Inc. $15.05 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2022 $18.36 1 ABBVIE INC. ($18.36)
2020 $56.80 3 KCI USA, Inc. ($37.24)
2019 $48.44 4 PFIZER INC. ($33.39)
2018 $15.96 1 Merck Sharp & Dohme Corporation ($15.96)

All Payment Transactions

9 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/30/2022 ABBVIE INC. VUITY (Drug) Food and Beverage In-kind items and services $18.36 General
Category: OPHTHALMOLOGY
02/28/2020 KCI USA, Inc. SNAP (Device), ACTIVAC Food and Beverage In-kind items and services $18.62 General
Category: TRAUMA EMERGENCY, INJURY, SURGERY
02/28/2020 KCI USA, Inc. ACTIVAC (Device), PREVENA, SNAP Food and Beverage In-kind items and services $18.62 General
Category: DEVICES
02/26/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.56 General
Category: Cardiovascular & Metabolism
12/19/2019 Allergan Inc. TEFLARO (Drug) Food and Beverage In-kind items and services $15.05 General
Category: ANTI-INFECTIVE
12/03/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $11.32 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/20/2019 PFIZER INC. ELELYSO (Drug), VYNDAQEL Food and Beverage In-kind items and services $11.22 General
Category: METABOLIC DISEASE
10/01/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $10.85 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
03/21/2018 Merck Sharp & Dohme Corporation JANUVIA (Drug), STEGLATRO Food and Beverage In-kind items and services $15.96 General
Category: ENDOCRINOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 90 159 $88,992 $11,217
2022 2 50 96 $54,426 $6,210
2021 2 46 155 $71,716 $18,381
2020 10 331 465 $149,662 $34,843
Total Patients
517
Total Services
875
Medicare Billing
$70,651
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 55 123 $73,116 $7,917 10.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 35 36 $15,876 $3,300 20.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 32 78 $46,488 $4,640 10.0%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 18 18 $7,938 $1,570 19.8%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 30 139 $63,940 $16,431 25.7%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 16 16 $7,776 $1,950 25.1%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 98 213 $57,510 $13,141 22.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 64 64 $25,280 $5,783 22.9%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 22 22 $16,500 $3,820 23.2%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 26 39 $15,015 $3,471 23.1%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 20 20 $10,200 $2,411 23.6%
99217 Hospital observation care on day of discharge Facility 2020 36 36 $9,720 $2,113 21.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 23 26 $5,408 $1,633 30.2%
99226 Subsequent observation care, typically 35 minutes per day Facility 2020 11 12 $4,644 $1,078 23.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 18 20 $2,720 $745.06 27.4%
99203 New patient office or other outpatient visit, typically 30 minutes Facility 2020 13 13 $2,665 $648.52 24.3%

About Dr. Nadezhda Gonzalez, MD

Dr. Nadezhda Gonzalez, MD is a Adult Medicine healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2014. The National Provider Identifier (NPI) number assigned to this provider is 1568874667.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nadezhda Gonzalez, MD has received a total of $139.56 in payments from pharmaceutical and medical device companies, with $18.36 received in 2022. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($139.56).

As a Medicare-enrolled provider, Gonzalez has provided services to 517 Medicare beneficiaries, totaling 875 services with total Medicare billing of $70,651. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Adult Medicine
  • Other Specialties Hospitalist, Family Medicine
  • Location Fort Myers, FL
  • Active Since 05/22/2014
  • Last Updated 01/11/2022
  • Taxonomy Code 207QA0505X
  • Entity Type Individual
  • NPI Number 1568874667

Products in Payments

  • ELIQUIS (Drug) $22.17
  • XARELTO (Drug) $19.56
  • ACTIVAC (Device) $18.62
  • SNAP (Device) $18.62
  • VUITY (Drug) $18.36
  • JANUVIA (Drug) $15.96
  • TEFLARO (Drug) $15.05
  • ELELYSO (Drug) $11.22

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Adult Medicine Doctors in Fort Myers